This website uses cookies so that we can provide you with the best user experience possible. Our Cookie Notice is part of our Privacy Policy and explains in detail how and why we use cookies. To take full advantage of our website, we recommend that you click on “Accept All”. You can change these settings at any time via the button "Update Cookie Preferences" in our Cookie Notice.
Technical cookies are required for the site to function properly, to be legally compliant and secure. Session cookies only last for the duration of your visit and are deleted from your device when you close your internet browser. Persistent cookies, however, remain and continue functioning on repeat visits.
CMS does not use any cookie based Analytics or tracking on our websites; see details here.
Personalisation cookies collect information about your website browsing habits and offer you a personalised user experience based on past visits, your location or browser settings. They also allow you to log in to personalised areas and to access third party tools that may be embedded in our website. Some functionality will not work if you don’t accept these cookies.
25/01/2013
Hamburg – The synlab Group has acquired Laboratoire Dr. Collard of Belgium, which operates a total of 41 blood testing centres in Belgium and Luxembourg. synlab is Europe’s leading laboratory services company for human, veterinary and environmental analysis. In 2012, it generated sales of around EUR 625 million, according to provisional figures. The purchase price was not disclosed.
A cross-border team from CMS DeBacker and CMS Hasche Sigle advised the Augsburg-based group on all aspects of the acquisition.
The lab service provider is a portfolio company of global private equity firm BC Partners. The synlab Group was formed at the end of 2009 through the merger of three lab chains in Germany, Austria and Italy, with CMS Hasche Sigle partner Dr Udo Simmat advising in the lead role. Since then it has grown organically and through further acquisitions.
The acquisition in Belgium is part of synlab's ongoing expansion strategy. It is now represented at 300 locations in a total of 18 European countries, as well as Turkey, Saudi Arabia and Dubai. The group has some 6,800 employees and carries out around 1 million analyses each day.
Dr Jacob Siebert, M&A, Private Equity, Lead Partner Germany
Dr Christoph Lächler, Corporate/M&A
Arnaud Van Oekel, Corporate/M&A, Lead Partner Belgium
David Prync, Corporate/M&A
Press Contact
[email protected]
Social Media cookies collect information about you sharing information from our website via social media tools, or analytics to understand your browsing between social media tools or our Social Media campaigns and our own websites. We do this to optimise the mix of channels to provide you with our content. Details concerning the tools in use are in our privacy policy.